# Metabolic Field Notes

> Clear, grounded insights on GLP-1s and daily habits


## Posts

- [Can a lower GLP-1 dose protect my muscles?](https://glianomics.com/blog/can-a-lower-glp-1-dose-protect-my-muscles/): Precision dosing means using the lowest GLP-1 dose that meets your treatment goal. Some clinicians call this “dose anchoring.” It requires medical supervision and body measurements.
- [Will I regain weight after stopping GLP-1 treatment?](https://glianomics.com/blog/will-i-regain-weight-after-stopping-glp-1-treatment/): What is it? After stopping GLP-1 treatment, hunger and cravings can return as the medicine’s effects fade. Your body may try to move back toward its earlier weight. What does it mean for me? Weight regain is common and is not a failure of willpower. Your risk depends on food reward, eating patterns, daily routines and previous weight loss and regain. These factors guide your planning but do not decide your future. What should I do now? What should I watch for? Watch for stronger cravings, stress eating and eating caused by places or situations. Notice whether your routines continue without […]
- [Is food noise the same as a food craving?](https://glianomics.com/blog/is-food-noise-the-same-as-a-food-craving/): A craving is a strong desire for a specific food. It often starts after a smell, place, feeling or time of day. Food noise is ongoing background thinking about food without clear hunger or desire.
- [What happens to my brain when I stop GLP-1 treatment?](https://glianomics.com/blog/what-happens-to-my-brain-when-i-stop-glp-1-treatment/): GLP-1 medicines reduce hunger, food cravings and thoughts about food. When the medicine leaves your body, these brain effects fade and food may become more noticeable again.
- [Why do food and smells seem different while using GLP-1?](https://glianomics.com/blog/why-do-food-and-smells-seem-different-while-using-glp-1/): What is it? Some people notice that food tastes flat, metallic or unusual while using GLP-1 medicines. Familiar smells may also become weaker, disappear or smell unpleasant. What does it mean for me? These changes are uncommon and usually temporary. They may happen because GLP-1 affects brain areas involved in taste, smell and food enjoyment. Many people improve within six to twelve weeks. What should I do now? What should I watch for? Watch whether symptoms started after a dose increase. Notice complete loss of smell, difficulty eating enough or faster weight loss because food feels unpleasant. Do not change your […]
- [Do I need eye monitoring while using GLP-1?](https://glianomics.com/blog/do-i-need-eye-monitoring-while-using-glp-1/): What is it? Diabetes can damage the tiny blood vessels at the back of your eye. This is called diabetic retinopathy, and it may cause no early symptoms. What does it mean for me? GLP-1 medicines can lower blood sugar quickly. This rapid change may temporarily worsen existing eye damage. The risk is higher if you already have retinopathy, very high HbA1c or long-standing poorly controlled diabetes. What should I do now? What should I watch for? Do not wait for eye symptoms because early changes may cause none. Keep your planned eye appointments. Pay special attention if your blood sugar […]
- [Why do I feel tired, dizzy or get headaches on GLP-1?](https://glianomics.com/blog/why-do-i-feel-tired-dizzy-or-get-headaches-on-glp-1/): What is it? GLP-1 medicines slow how quickly food leaves your stomach. You may eat and drink less, leaving your body with less energy and water. What does it mean for me? Mild tiredness, brief dizziness when standing and a dull headache can happen during treatment. These symptoms may improve when you eat small amounts regularly and drink enough water. What should I do now? What should I watch for? Watch for worsening dizziness, fainting, vision changes or an unusual heartbeat. Notice whether symptoms make it difficult to walk, think or remain standing. When should I get medical help? Call your […]
- [GLP-1 side effects: What is common and what is serious?](https://glianomics.com/blog/glp-1-side-effects-what-is-common-and-what-is-serious/): GLP-1 medicines slow how quickly food moves through your gut. While your body adjusts, they can cause nausea, vomiting, constipation, diarrhoea, bloating, headache, dizziness or tiredness.
- [Constipation, bloating and reflux while using GLP-1](https://glianomics.com/blog/constipation-bloating-and-reflux-while-using-glp-1/): GLP-1 medicines slow the movement of food through your stomach and gut. This can cause hard stools, trapped gas, bloating and acid reflux.
- [Nausea after a GLP-1 injection: What is normal?](https://glianomics.com/blog/nausea-after-a-glp-1-injection-what-is-normal/): GLP-1 medicines slow how quickly food leaves your stomach. This helps you feel full, but it can also cause nausea while your body adjusts.
- [How should I prepare for a doctor visit while using GLP-1?](https://glianomics.com/blog/how-should-i-prepare-for-a-doctor-visit-while-using-glp-1/): What is it? Preparing means keeping a short record between visits. It helps you explain important changes without depending only on memory. What does it mean for me? GLP-1 treatment can affect your appetite, digestion, energy and eating habits. These changes may happen slowly. Simple notes help your doctor understand the pattern and use your visit well. What should I do now? What should I watch for? Watch for symptoms that repeat, become worse or affect your daily life. Notice changes in eating, drinking, sleep, mood and energy. Note whether symptoms happen near your dose day. When should I get medical […]
- [Why does my mind keep imagining bad outcomes?](https://glianomics.com/blog/why-does-my-mind-keep-imagining-bad-outcomes/): Why does my mind keep imagining bad outcomes?
- [Sudden Vision Loss on GLP-1: What Counts as Urgent](https://glianomics.com/blog/sudden-vision-loss-glp1-what-counts-as-urgent/): Not all vision changes on GLP-1 are emergencies -- but some are. This guide gives you a clear triage framework so you know when to go to the ER and when to wait.
- [GLP-1 and the Brain: Food Noise, Cravings, and Appetite Signals](https://glianomics.com/blog/glp1-brain-food-noise-cravings-appetite-signals/): GLP-1 medications reduce food noise, cravings, and appetite via three distinct brain pathways. Here's what the evidence shows for each, and why conflating them leads to overclaiming and underexplaining.
- [GLP-1, Fertility, and Unplanned Pregnancy: Why Counseling Matters](https://glianomics.com/blog/glp1-fertility-unplanned-pregnancy-counseling/): GLP-1 medications can restore ovulation in women with PCOS and, in the case of tirzepatide, reduce oral contraceptive effectiveness. Learn why pre-treatment counseling needs to address both mechanisms.
- [Periods Changed After Starting GLP-1? What Women Should Track](https://glianomics.com/blog/periods-changed-glp1-what-women-should-track/): GLP-1 medication changing your menstrual cycle? This guide explains what's expected, what needs a doctor call, and how to track cycle changes effectively.
- [Eye Check Before Starting a GLP-1? What Diabetic Users Should Ask First](https://glianomics.com/blog/eye-check-before-glp1-diabetic-users/): Do you have diabetes and your doctor just prescribed a GLP-1? Here's why a baseline eye exam before your first dose matters and the questions worth asking first.
- [CBT and Habit Modification for Obesity: The CBT-FIRE Framework](https://glianomics.com/blog/cbt-fire-method-habit-modification-obesity/): CBT is the most effective behavioral intervention for obesity. The CBT-FIRE framework - Focus, Identify, Reshape, Embed - makes the evidence actionable for clinical settings.
- [GLP-1 and Smell/Taste Changes: What Users Are Reporting](https://glianomics.com/blog/glp1-smell-taste-changes-side-effects/): GLP-1 drugs can alter taste and smell through brain receptors - not just gut effects. Here's what the data shows, what types of changes to expect, and when to tell your doctor.
- [The GLP-1 Birth Control Risk: Why Your Pill Might Fail](https://glianomics.com/blog/glp1-birth-control-risk-oral-contraceptive/): GLP-1 Drugs and Birth Control: Which Medications Actually Affect Your Pill
- [The Weight That Moves: How Activity and Weight Trajectory Predict Long-Term Survival](https://glianomics.com/blog/weight-trajectory-mortality-risk/): A 442,666-person cohort found lean, metabolically unhealthy adults die more often than metabolically healthy obese adults - activity changed the odds for both.
- [Eye Monitoring on GLP-1: A Simple Guide for People with Diabetes](https://glianomics.com/blog/glp1-retinopathy-eye-monitoring/): Starting GLP-1 therapy with diabetic retinopathy? Learn why eye monitoring matters, who is most at risk, and 3 steps before starting semaglutide.
- [Semaglutide and NAION: Rare Risk, Serious Symptom](https://glianomics.com/blog/semaglutide-naion-rare-risk-serious-symptom/): NAION is a very rare semaglutide side effect, per EMA's 2025 review - but a genuine red flag if it happens. Here is what the data shows and what to do.
- [GLP-1 and PCOD/PCOS: A Safe, Honest Explanation](https://glianomics.com/blog/glp-1-pcos-pcod-safe-honest-explanation/): Can GLP-1 medicines help women with PCOS? An endocrinologist explains the real benefits, honest limits, and what to watch - including pregnancy planning guidance.
- [GLP-1 and Eyes: Blurry Vision, Diabetes, and What Users Should Know](https://glianomics.com/blog/glp1-eyes-blurry-vision-diabetes/): Blurry vision after starting GLP-1? Here is the difference between a common, temporary side effect and a sign your eyes need checking - with real trial data.
- [Tired, Dizzy, or Getting Headaches on GLP-1? Here Is What Is Going On](https://glianomics.com/blog/fatigue-dizziness-headache-glp1-side-effects/): Meera, a 34-year-old teacher in Chennai, had been on her GLP-1 injection for three weeks. Thenausea had mostly passed. But by early afternoon, she was exhausted. When she stood up from herdesk, the room tilted for a moment. And by evening, a dull headache had settled behind her eyes. She searched online. She found lists of side effects, but no one explained why these threethings were happening at the same time. This article is for education only and does not replace medical advice. If you are on a GLP-1 medication and have concerns about how you feel, talk to your doctor. […]
- [GLP-1 Side Effects: What Is Common, What Is Serious, and What to Track](https://glianomics.com/blog/glp1-side-effects-common-serious-what-to-track/): Most GLP-1 side effects are temporary. A few need urgent attention. Learn which is which, and what to write down before your next doctor visit.
- [Constipation, Bloating, and Reflux: The Gut Side of GLP-1](https://glianomics.com/blog/constipation-bloating-and-reflux-the-gut-side-of-glp-1/): Starting a GLP-1 medication and dealing with constipation, bloating, or heartburn? Learn why these gut side effects happen and what you can do about them.
- [Nausea After Your GLP-1 Injection: What's Normal, and When to Call Your Doctor](https://glianomics.com/blog/nausea-after-glp1-injection-normal-when-to-call-doctor/): Nausea After Your GLP-1 Injection: What's Normal, and When to Call Your Doctor
- [How to Prepare for a Doctor Visit While Using GLP-1](https://glianomics.com/blog/how-to-prepare-for-a-doctor-visit-while-using-glp-1/): A short GLP-1 follow-up visit gets sharper with a little preparation. What to log between visits, how to turn notes into questions, and where tracking's limits are.
- [Latest Research on GLP-1 and Inflammation: Mechanisms, Implications, and What to Do While on Therapy](https://glianomics.com/blog/glp1-anti-inflammatory-effects-mechanisms/): GLP-1 drugs lower CRP and TNF-alpha beyond weight loss. Here's what the research on GLP-1 anti-inflammatory effects actually shows - and what to do.
- [GLP-1 Receptor Agonists Beyond Obesity: What 123 Meta-Analyses Actually Show](https://glianomics.com/blog/glp1-clinical-outcomes-beyond-obesity/): A 2026 umbrella review graded 123 meta-analyses on GLP-1 receptor agonists across seven organ systems. Here's where the evidence is strong, and where it isn't.
- [OSA and GLP-1 Drugs: What the SURMOUNT-OSA Trial Actually Showed](https://glianomics.com/blog/osa-and-glp-1-drugs-what-the-surmount-osa-trial-actually-showed/): Part 3 of the OSA Trilogy You were prescribed a CPAP machine, brought it home, and tried to sleep with a mask strapped to your face. For a lot of people, that’s where the treatment story ends. Not because the machine doesn’t work, but because using it every night, long-term, is harder than the prescription makes it sound. That difficulty has real consequences. Real-world data consistently show that long-term CPAP adherence (defined as at least four hours per night on at least 70% of nights) sits at roughly 46 to 54% at 90 days to 12 months.[2] For those people, untreated […]
- [Sleep Apnea and Insulin Resistance: What's Happening to Your Body Every Night](https://glianomics.com/blog/sleep-apnea-insulin-resistance/): Sleep apnea drives insulin resistance through nightly hypoxic stress. How oxygen dips disrupt blood sugar, appetite hormones, and blood pressure every night
- [Obstructive Sleep Apnea in India: Why 104 Million Cases Stay Hidden](https://glianomics.com/blog/obstructive-sleep-apnea-india/): A 2023 meta-analysis found 104M working-age Indians may have sleep apnea. Here's why it stays invisible -- and why the metabolic stakes are higher than anyone is saying
- [Fatty Liver Disease Burden in India: What National Survey Data Reveals About a Hidden Metabolic Crisis](https://glianomics.com/blog/fatty-liver-disease-burden-india/): India's fatty liver disease burden affects an estimated 250-300 million adults -- yet most remain undiagnosed. South Asian biology explains the hidden scale.
- [Same Weight Gain, Different Metabolic Risk](https://glianomics.com/blog/weight-gain-metabolic-risk-south-asian/): The same 4.5kg gain cut insulin sensitivity 38% in South Asian men but just 7% in White Europeans. Here's what drives the metabolic risk gap.
- [Strength Training for GLP-1 Users: A Simple Muscle-Preservation Guide](https://glianomics.com/blog/glp1-strength-training/): GLP-1 weight loss works best with a muscle-preservation plan. Start here: a simple, practical guide to strength training on medication.
- [The Weight Loss Trio: Understanding Muscle Loss, Appetite, and Nausea on GLP-1s](https://glianomics.com/blog/glp1-muscle-loss-appetite-nausea/): Understand why GLP-1 medications cause muscle loss, appetite suppression, and nausea, and how to manage each with evidence-based strategies.
- [GLP-1 Agonists and Sleep Disorders: How the Treatment Protocol Changed](https://glianomics.com/blog/glp1-sleep-apnea-treatment-protocol/): OSA is the most clinically well-studied sleep disorder in the GLP-1 space and the one where a genuine protocol shift occurred with tirzepatide's FDA approval for OSA in December 2024. This keyword is specific enough to avoid massive DA competition, maps naturally to the article title and H1, and matches how patients and practitioners search when the treatment question is foregrounded.
- [GLP-1 and Fatty Liver Disease: What the Trial Data Keeps Showing Beyond Weight Loss](https://glianomics.com/blog/glp-1-and-fatty-liver-disease-beyond-weight-loss/): GLP-1 agonists improve fatty liver through direct hepatic mechanisms, not just weight loss. What the ESSENCE trial interim biopsy data shows about NASH resolution.
- [GLP-1 Benefits Beyond Weight Loss: Evidence Review](https://glianomics.com/blog/glp1-benefits-beyond-weight-loss/): GLP-1 agonists cut cardiovascular events, protect kidneys, and reverse liver disease. An evidence-graded review of SELECT, FLOW, and ESSENCE trials.
- [Staying Hydrated on GLP-1 Medication This Summer](https://glianomics.com/blog/glp1-hydration-summer-heat/): GLP-1 medications suppress thirst signals alongside hunger. Learn why dehydration sneaks up on GLP-1 users, and how to stay safe this summer.
- [GLP-1 Drugs and PCOS Fertility: Can They Restore Ovulation?](https://glianomics.com/blog/glp1-pcos-fertility-restored-ovulation/): Women with PCOS are regaining fertility on GLP-1 medications. Here is the mechanism, and the pregnancy risk to know.
- [GLP-1 Success: A Data-Driven Framework for Better Results](https://glianomics.com/blog/glp1-success-data-driven-framework/): The scale misses what matters on GLP-1 therapy. Track 4 key signals to see what is really changing in your body.
- [Saving Your Skin: What GLP-1 Users Need to Know Before Summer](https://glianomics.com/blog/ozempic-face-glp1-skin-summer/): Ozempic Face is real. GLP-1s also suppress thirst and thin the skin barrier. Here is the practical summer skin protocol
- [Precision Dosing: Can GLP-1 Microdoses Solve Muscle Loss and Inflammation?](https://glianomics.com/blog/glp1-microdosing-muscle-inflammation/): Standard GLP-1 dose escalation may be accelerating muscle loss. Here's what early microdosing research shows about body composition and inflammation
- [Does GLP-1 Cause Hair Loss? What the Data Shows](https://glianomics.com/blog/does-glp1-cause-hair-loss/): Hair loss on semaglutide gets blamed on the drug. The mechanism points elsewhere. What telogen effluvium actually is, and what you can do about it.
- [The Relapse Prediction Model: Why Some GLP-1 Users Keep the Weight Off](https://glianomics.com/blog/the-relapse-prediction-model/): Most GLP-1 users regain two-thirds of lost weight within a year of stopping.  But not everyone. The difference comes down to 4 measurable factors - and you can assess them now, while the medication is still working.
- [Why GLP-1s Work Even When You Can't Stop Thinking About Food](https://glianomics.com/blog/why-glp-1s-work-even-when-you-cant-stop-thinking-about-food/): Weight regain after stopping GLP-1 medications is not a willpower failure.  It is biology reclaiming a defended setpoint. The research on who avoids it is getting specific. Here is the 4-factor relapse prediction model
- [Food Noise Isn't Cravings. Here's the Brain Scan Difference](https://glianomics.com/blog/food-noise/): Is food noise a reward signal or a cognitive loop? Explore the brain scan differences between the mesolimbic dopamine system and the Default Mode Network.
- [DMN: The Rumination Network and Maladaptive Prospection](https://glianomics.com/blog/dmn-rumination-network/): How the default mode network drives maladaptive prospection, chronic rumination, and its metabolic cost. Evidence-based analysis from Metabolic Field Notes. In 2001, Marcus Raichle was reviewing PET scan data when he noticed something his study was not designed to find. When participants rested between cognitive tasks (doing nothing, watching a blank screen) a specific set of brain regions became more active, not less. The brain was not quieting. It was running a program. Raichle named it the default mode network. The finding reversed a foundational assumption in neuroscience. For decades, researchers had treated the resting brain as the absence of activity, […]
- [When You Stop GLP-1s, Your Brain Notices First](https://glianomics.com/blog/stop-glp1-dmn-rebound/): GLP-1 cessation affects six brain systems simultaneously. New data shows the DMN and reward circuits reactivate before appetite returns – and what behavioral training can do about it. The weight comes back. Not all at once , not from one meal that went sideways. For most people who stop GLP-1 therapy, the return begins before any behavioral change: food reappearing in thought before it reappears on the plate. That shift is not vague or psychological. It has a neurological address. Introduction The STEP 4 trial established the weight trajectory with precision. Participants who had lost an average of 10.6% of their […]
- [Cognitive Energetics & GLP-1: The Hidden Reason Behavior Change Feels Hard](https://glianomics.com/blog/cognitive-energetics-glp1-behavior-change/): Discover how cognitive energetics explains why behavior change feels hard—even on GLP-1. Learn the neuroscience of effort allocation and how to build habits that actually stick.
- [The Five Movement Signals Your Metabolism Still Understands](https://glianomics.com/blog/movement-signals-your-metabolism/): Your metabolism does not recognize gym memberships or workout streaks. It responds to five ancient physical cues - signals that tell the body how energy should be used.

## Pages

- [Contact Thank you](https://glianomics.com/blog/contact-thankyou/): Thank you for connecting. Your message is in our inbox. While our team reviews it, why not dive into our most-read insights on habit-building and metabolic optimization?
- [Thank You -Newsletter subscription](https://glianomics.com/blog/thank-you/): Thank you for subscribing. Thank you! You’ve been added to the list. We’ll reach out once the first Metabolic Field Notes are ready for release.
- [Contact](https://glianomics.com/blog/contact/)
- [Metabolic Field Notes](https://glianomics.com/blog/): Metabolic science, examined with clarity. Clear, grounded insights on GLP-1s and daily habits Join the Field Notes Coming Soon: Join the waitlist for our official launch.One core insight per issue. A calm, research-aware approach to metabolic science and behavioral adaptation delivered weekly.

## Optional

- [Agent (MCP protocol)](websites-agents.hostinger.com/glianomics.com/mcp)

[comment]: # (Generated by Hostinger Tools Plugin)